Studies have found that miR-552 can increase the expression of Bcl-2 in HCC cells by targeting RUNX3, and reduce the expression of caspase3 and Bax, thereby inhibiting the apoptosis of HCC cells 26. Here, BCL2 is linked to hepatocellular carcinoma.